AtriCure, Inc.
NASDAQ: ATRCCincinnati, US · Founded 2000 · 1,391 employees on LinkedIn · 1 known investors
AtriCure develops medical devices for treating atrial fibrillation and related cardiac conditions, serving electrophysiologists, cardiothoracic surgeons, and thoracic surgeons globally. The company offers ablation systems, left atrial appendage exclusion devices, minimally invasive therapies, and cryoprobes for nerve ablation and pain management in cardiac procedures.
Founders & leadership
MH
Michael H. CarrelinPresident and Chief Executive Officer
Investors · 1
Frequently asked questions
- What does AtriCure, Inc. do?
- AtriCure develops medical devices for treating atrial fibrillation and related cardiac conditions, serving electrophysiologists, cardiothoracic surgeons, and thoracic surgeons globally. The company offers ablation systems, left atrial appendage exclusion devices, minimally invasive therapies, and cryoprobes for nerve ablation and pain management in cardiac procedures.
- Who are AtriCure, Inc.'s investors?
- AtriCure, Inc.'s investors include Camden Partners.
- Where is AtriCure, Inc. headquartered?
- AtriCure, Inc. is headquartered in Cincinnati, US.